Abstract
The resurgence of drug resistant tuberculosis (TB) is a major global healthcare problem. Mycobacterium tuberculosis (MTB), TBs causative agent, evades the host immune system and drug regimes by entering prolonged periods of nonproliferation or dormancy. The identification of genes essential to the bacterium in its dormancy phase infections is a key strategy in the development of new anti-TB therapeutics. The rapid expansion of TB-related genomic data sources including DNA sequences, transcriptomic and proteomic profiles, and genome-wide essentiality data, present considerable opportunities to apply advanced computational analyses to predict potential drug targets. However, the translation of in silico predictions to effective clinical therapies remains a significant challenge.
Keywords: Computational Biology, Drug Discovery, Anti-Tuberculosis, Mycobacterium tuberculosis (MTB), immune system, DNA sequences
Infectious Disorders - Drug Targets
Title: Computational Biology in Anti-Tuberculosis Drug Discovery
Volume: 9 Issue: 3
Author(s): Dennis J. Murphy and James R. Brown
Affiliation:
Keywords: Computational Biology, Drug Discovery, Anti-Tuberculosis, Mycobacterium tuberculosis (MTB), immune system, DNA sequences
Abstract: The resurgence of drug resistant tuberculosis (TB) is a major global healthcare problem. Mycobacterium tuberculosis (MTB), TBs causative agent, evades the host immune system and drug regimes by entering prolonged periods of nonproliferation or dormancy. The identification of genes essential to the bacterium in its dormancy phase infections is a key strategy in the development of new anti-TB therapeutics. The rapid expansion of TB-related genomic data sources including DNA sequences, transcriptomic and proteomic profiles, and genome-wide essentiality data, present considerable opportunities to apply advanced computational analyses to predict potential drug targets. However, the translation of in silico predictions to effective clinical therapies remains a significant challenge.
Export Options
About this article
Cite this article as:
Murphy J. Dennis and Brown R. James, Computational Biology in Anti-Tuberculosis Drug Discovery, Infectious Disorders - Drug Targets 2009; 9 (3) . https://dx.doi.org/10.2174/1871526510909030319
DOI https://dx.doi.org/10.2174/1871526510909030319 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
FtsZ: A Novel Target for Tuberculosis Drug Discovery
Current Topics in Medicinal Chemistry A Comprehensive Systemic Literature Review of Pericardial Decompression Syndrome: Often Unrecognized and Potentially Fatal Syndrome
Current Cardiology Reviews Approaches to Target Profiling of Natural Products
Current Medicinal Chemistry Polypharmacology in a Single Drug: Multitarget Drugs
Current Medicinal Chemistry How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy
Anti-Cancer Agents in Medicinal Chemistry An Update on the Chemistry and Medicinal Chemistry of Novel Antimycobacterial Compounds
Current Topics in Medicinal Chemistry QSAR and Docking Studies of N-hydroxy Urea Derivatives as Flap Endonuclease-1 Inhibitors
Current Computer-Aided Drug Design Do You See What I See: Recognition of Protozoan Parasites by Toll-Like Receptors
Current Immunology Reviews (Discontinued) Ibalizumab-Human CD4 Receptor Interaction: Computational Alanine Scanning Molecular Dynamics Studies
Current Computer-Aided Drug Design Meet the Editorial Board:
Current Medicinal Chemistry Patent Selections
Recent Patents on DNA & Gene Sequences Surreptitious TB Infections with Recently Identified DM People: A Cross- Sectional Study
Infectious Disorders - Drug Targets Acylhydrazide Schiff Bases: DPPH Radical and Superoxide Anion Scavengers
Medicinal Chemistry Essential Roles of Toll-Like Receptors in Atherosclerosis
Current Medicinal Chemistry Elucidating Unusual Modes of Action and Resistance of Antibacterial Peptides
Current Topics in Medicinal Chemistry Balancing the Double-Edged Sword: Metal Ion Homeostasis and the Ulcer Bug
Current Medicinal Chemistry Recent Advances Using Supercritical Fluid Techniques for Pulmonary Administration of Macromolecules via Dry Powder Formulations
Drug Delivery Letters Biotechnology in the Development of New Vaccines and Diagnostic Reagents Against Tuberculosis
Current Pharmaceutical Biotechnology Pharmacotherapy in Systemic Lupus Erythematosus
Current Rheumatology Reviews Recombinant Mycobacterium bovis BCG as an HIV Vaccine Vector
Current HIV Research